Display options
Cite
Wild R, Weedin EA, Gill EA. Women's Health Considerations for Lipid Management. Endocrinol Metab Clin North Am. 2016;45(1):65-85doi: 10.1016/j.ecl.2015.09.005.
Wild, R., Weedin, E. A., & Gill, E. A. (2016). Women's Health Considerations for Lipid Management. Endocrinology and metabolism clinics of North America, 45(1), 65-85. https://doi.org/10.1016/j.ecl.2015.09.005
Wild, Robert, et al. "Women's Health Considerations for Lipid Management." Endocrinology and metabolism clinics of North America vol. 45,1 (2016): 65-85. doi: https://doi.org/10.1016/j.ecl.2015.09.005
Wild R, Weedin EA, Gill EA. Women's Health Considerations for Lipid Management. Endocrinol Metab Clin North Am. 2016 Mar;45(1):65-85. doi: 10.1016/j.ecl.2015.09.005. PMID: 26892998.
Copy Download .nbib Format: NLM
Share it on

Endocrinol Metab Clin North Am. 2016 Mar;45(1):65-85. doi: 10.1016/j.ecl.2015.09.005.

Women's Health Considerations for Lipid Management.

Endocrinology and metabolism clinics of North America

Robert Wild, Elizabeth A Weedin, Edward A Gill

Affiliations

  1. Section of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, 1100 N Lindsay Ave, Oklahoma City, OK 73104, USA. Electronic address: [email protected].
  2. Section of General Obstetrics and Gynecology, Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, 1100 N Lindsay Ave, Oklahoma City, OK 73104, USA.
  3. Division of Cardiology, UW Department of Medicine, Harborview Medical Center Echocardiography, University of Washington School of Medicine, Seattle University, 325 Ninth Avenue, Box 359748, Seattle, WA 98104-2499, USA.

PMID: 26892998 DOI: 10.1016/j.ecl.2015.09.005

Abstract

Understanding opportunities to reduce dyslipidemia before, during, and after pregnancy has major implications for cardiovascular disease risk prevention for the entire population. The best time to screen for dyslipidemia is before pregnancy or in the early antenatal period. The differential diagnosis of hypertriglyceridemia in pregnancy is the same as in nonpregnant women except that clinical lipidologists need to be aware of the potential obstetric complications associated with hypertriglyceridemia. Dyslipidemia discovered during pregnancy should be treated with diet and exercise intervention, as well as glycemic control if indicated. A complete lipid profile assessment during each trimester of pregnancy is recommended.

Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords: Dyslipidemia; Hypertriglyceridemia; Lipids; Women’s health

Publication Types